Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole CR for RLS with Sleep Disturbance
NCT00373542Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in restless legs syndrome (RLS) comparing Ropinirole CR with Placebo (2 arms). Primary endpoints: Periodic Limb Movements in Sleep associated with Arousal Index at 12 weeks and Sleep Latency at 12 weeks. Started Oct 2006; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00373542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373542.